Drug Information

Drug General Information
Drug ID
D09ZNB
Former ID
DNCL002456
Drug Name
RG7112
Drug Type
Small molecular drug
Indication Hematological malignancies [ICD9: 200-209; ICD10:C81-C86] Phase 1 [522159]
Company
Roche
Structure
Download
2D MOL

3D MOL
Formula
C37H46Cl2N4O4S
Canonical SMILES
CCOC1=C(C=CC(=C1)C(C)(C)C)C2=NC(C(N2C(=O)N3CCN(CC3)CCS(<br />=O)(=O)C)(C)C4=CC=C(C=C4)Cl)(C)C5=CC=C(C=C5)Cl
InChI
1S/C37H46Cl2N4O4S/c1-8-47-32-25-28(35(2,3)4)13-18-31(32)33-40-36(5,26-9-14-29(38)15-10-26)37(6,27-11-16-30(39)17-12-27)43(33)34(44)42-21-19-41(20-22-42)23-24-48(7,45)46/h9-18,25H,8,19-24H2,1-7H3/t36-,37+/m0/s1
InChIKey
CMIJXZWOIKQHLL-PQQNNWGCSA-N
PubChem Compound ID
56952026
PubChem Substance ID
135664200, 136350030
References
Ref 522159ClinicalTrials.gov (NCT00559533) A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.